Description:
Discover the dynamic landscape of the medical device industry with Kalorama Information’s 13th edition of the Global Market for Medical Devices report. Gain valuable insights into market trends, competitive dynamics, and future forecasts in this ever-evolving sector.
Industry Overview:
The medical device industry, a cornerstone of healthcare, continues to evolve through technological advancements, impacting patient care and longevity. Despite challenges such as stringent regulations and pricing negotiations, this sector remains resilient and attractive to investors.
Key Highlights:
- Insights into regulations and market dynamics across 50 world markets.
- Market size estimates and forecasts up to 2028 for global and country-specific markets.
- Index of leading device companies and their market strategies.
- Analysis of specific device categories, including cardiovascular, dialysis, respiratory, and more.
- Examination of market drivers, limiters, and future growth opportunities.
Market Focus:
- Cardiovascular devices
- Dental equipment
- Dialysis equipment
- Imaging technologies
- In vitro diagnostics (IVD)
- Minimally invasive surgical instruments
- Orthopedic devices
- Patient monitoring devices
- Respiratory devices
- Wound care products
Competitive Landscape:
The market is highly fragmented, with top companies like Medtronic, J&J, Siemens Healthineers, Danaher, and Philips dominating. Rankings can shift due to acquisitions, and the top 15 companies continue to consolidate their market share. The industry is also characterized by thousands of smaller companies, particularly in the United States.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Top 20 Device Markets, by Country, 2023-2028 ($ billions)
| Country | 2023 | 2028 | CAGR 2023-2028 |
| United States | $XX Billion | $XX Billion | XX% |
| China | $XX Billion | $XX Billion | XX% |
| Japan | $XX Billion | $XX Billion | XX% |
| Germany | $XX Billion | $XX Billion | XX% |
| France | $XX Billion | $XX Billion | XX% |
| United Kingdom | $XX Billion | $XX Billion | XX% |
| Italy | $XX Billion | $XX Billion | XX% |
| Spain | $XX Billion | $XX Billion | XX% |
| Brazil | $XX Billion | $XX Billion | XX% |
| India | $XX Billion | $XX Billion | XX% |
| Canada | $XX Billion | $XX Billion | XX% |
| Australia | $XX Billion | $XX Billion | XX% |
| Russia | $XX Billion | $XX Billion | XX% |
| Netherlands | $XX Billion | $XX Billion | XX% |
| Taiwan | $XX Billion | $XX Billion | XX% |
| South Korea | $XX Billion | $XX Billion | XX% |
| Switzerland | $XX Billion | $XX Billion | XX% |
| Sweden | $XX Billion | $XX Billion | XX% |
| Mexico | $XX Billion | $XX Billion | XX% |
| Turkey | $XX Billion | $XX Billion | XX% |
Source: Kalorama Information
